1. Home
  2. THG vs KRYS Comparison

THG vs KRYS Comparison

Compare THG & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Insurance Group Inc

THG

Hanover Insurance Group Inc

HOLD

Current Price

$223.16

Market Cap

8.1B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$346.58

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THG
KRYS
Founded
1852
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
9.6B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
THG
KRYS
Price
$223.16
$346.58
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
$194.60
$297.60
AVG Volume (30 Days)
282.4K
508.3K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
2.14%
N/A
EPS Growth
55.21
128.00
EPS
10.58
3.62
Revenue
$6,594,400,000.00
$389,130,000.00
Revenue This Year
$2.71
$38.74
Revenue Next Year
$4.43
$32.53
P/E Ratio
$21.09
$93.10
Revenue Growth
5.72
33.94
52 Week Low
$166.54
$143.09
52 Week High
$236.07
$382.54

Technical Indicators

Market Signals
Indicator
THG
KRYS
Relative Strength Index (RSI) 52.88 54.09
Support Level $176.82 $253.89
Resistance Level $225.29 $382.33
Average True Range (ATR) 4.19 10.03
MACD -1.24 1.62
Stochastic Oscillator 39.22 98.36

Price Performance

Historical Comparison
THG
KRYS

About THG Hanover Insurance Group Inc

The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business through Hanover Insurance, Citizens and other THG subsidiaries. The company conducts business operations through four operating segments: Core Commercial, Specialty, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: